Zdrowie i gospodarka · 08/05/2007
FDA Reopens Comment Period for Absorbable Hemostatic Device Reclassification
The FDA is extending the comment period for a proposed rule reclassifying an absorbable hemostatic device from class III to class II until June 7, 2007, in response to requests for an extension.
Source: Federal Register — Food and Drug AdministrationOpen original release →